Roquefort Therapeutics (LON:ROQ) Stock Price Down 12%

Roquefort Therapeutics plc (LON:ROQGet Free Report)’s share price traded down 12% on Friday . The company traded as low as GBX 4.30 ($0.05) and last traded at GBX 4.31 ($0.05). 451,268 shares were traded during trading, an increase of 48% from the average session volume of 305,641 shares. The stock had previously closed at GBX 4.90 ($0.06).

Roquefort Therapeutics Price Performance

The company has a 50 day simple moving average of GBX 4.65 and a 200-day simple moving average of GBX 6.30. The stock has a market capitalization of £5.57 million, a P/E ratio of -490.00 and a beta of 0.05.

About Roquefort Therapeutics

(Get Free Report)

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action.

Recommended Stories

Receive News & Ratings for Roquefort Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roquefort Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.